Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging
ClinicalTrials.gov study NCT03417830. IPD Sharing: YES. Countries: 1. Publications: 1.
Open Label Study Telmisartan and Amlodipine in Hypertension
ClinicalTrials.gov study NCT00614380. IPD Sharing: Not stated. Countries: 12. Publications: 1.
A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01761266. IPD Sharing: Not stated. Countries: 21. Publications: 9.
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
ClinicalTrials.gov study NCT01194973. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Multicenter, Open-label, Safety and Tolerability Study
ClinicalTrials.gov study NCT01649557. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3
ClinicalTrials.gov study NCT01260350. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20
ClinicalTrials.gov study NCT03538626. IPD Sharing: NO. Countries: 1. Publications: 4.
Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds
ClinicalTrials.gov study NCT04240886. IPD Sharing: NO. Countries: 4. Publications: 1.
A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)
ClinicalTrials.gov study NCT02018861. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures
ClinicalTrials.gov study NCT00938431. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension
ClinicalTrials.gov study NCT00881530. IPD Sharing: Not stated. Countries: 21. Publications: 1.
An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam
ClinicalTrials.gov study NCT00761774. IPD Sharing: Not stated. Countries: 11. Publications: 1.
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
ClinicalTrials.gov study NCT00281632. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
ClinicalTrials.gov study NCT03251378. IPD Sharing: NO. Countries: 1. Publications: 1.
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
ClinicalTrials.gov study NCT02057718. IPD Sharing: NO. Countries: 4. Publications: 1.
Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
ClinicalTrials.gov study NCT02317627. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de
ClinicalTrials.gov study NCT00369161. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries
ClinicalTrials.gov study NCT03080935. IPD Sharing: YES. Countries: 7. Publications: 3.
An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor
ClinicalTrials.gov study NCT01619774. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
ClinicalTrials.gov study NCT02565186. IPD Sharing: YES. Countries: 3. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.